Jean-Paul (John) Audette
Mr. Audette joined MitoSciences in May of 2006. Prior to that he was the Founder and Managing Director in 2003 of Audette Group Consulting, a strategic consultancy for early-stage high technology companies. Beginning in 1999 Mr. Audette was a Senior Vice President at Outrider (now WPP) part of Tempus Group Plc, an international marketing services conglomerate based in London. Beginning in 1994 Mr. Audette was the Sr. Vice President and Chief Strategist at MMG Inc. until its acquisition by Outrider/Tempus in 1999. Prior to MMG Mr. Audette held various marketing management positions with information services companies JWP and PCX. Mr. Audette has a B.A. in human ecology from the University of Oregon and is a licensed Emergency Medical Technician.
James G. Murray, Ph.D.
Dr. Murray joined MitoSciences in 2004. Prior to that he served as a post-doctoral research associate in the Institute of Molecular Biology at the University of Oregon where he has studied the organization of the multi-subunit enzymes of oxidative phosphorylation as well as developing novel methods to generate and characterize antibodies for the isolation of these complexes. Dr. Murray graduated from the University of Edinburgh, UK, in 1994 with a B.Sc. honors degree in Biochemistry. In 1998 he was awarded a Ph.D. from the University of Leeds, UK, for studies upon the structure/function of the yeast vacuolar type ATPase under the supervision of Prof. J. B. C. Findlay.
Roderick A. Capaldi, D.Phil.
Dr. Capaldi was educated at London University (BSc) and York University (D.Phil.). Dr. Capaldi co-founded MitoSciences in 2004 with Dr. Marusich and served as CSO until May 2011. Previous to his full time role at MitoSciences he was Knight Professor of the Arts and Sciences and member of the prestigious Institute of Molecular Biology at the University of Oregon. Publisher of more than 250 papers in the area of mitochondrial function and disease, Dr. Capaldi has been Established Investigator of the American Heart Association and recipient of the Medical Research Foundation of Oregon Medal.
Michael F. Marusich, Ph.D.
Dr. Marusich received his BS in Zoology from the University of Michigan in 1975 and M.S. and Ph.D. degrees in Biology from Northwestern University in 1976 and 1981 respectively. He established the University of Oregon Monoclonal Antibody Facility in 1986, and served as Director of the facility until 2008. In 2004, Dr. Marusich co-founded MitoSciences with Dr. Roderick Capaldi and served as COO until May 2011. Dr. Marusich has published 40 papers on the development, characterization and use of novel antibodies and immunoassays for the study of early embryonic development, metabolism and mitochondrial disorders.